Impact of race on prostate cancer selection and cause-specific mortality: A SEER database analysis. Background: Prostate volume affects whether patients qualify for brachytherapy (desired size ≥20mL ...
Associations between patient sociodemographic factors and non-treatment for localized prostate cancer. N represents the total number of biopsies in each variable category. The mean difference is the ...
Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process for generating prostate volume ...
Under adequate local anesthesia, the size of the transrectal ultrasound probe made no difference to pain perception during transrectal ultrasound guided prostate biopsy, according to a PubMed report.
Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.
High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...
An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical prostatectomy in an early analysis of a first-ever randomized trial. After 6 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results